{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"glepaglutide","name":"Glepaglutide","url":"https://peptidescanner.com/peptides/glepaglutide/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":9,"objects":{"clinicaltrials-gov-nct03279302-glepaglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03279302-glepaglutide:v1","objectPathId":"clinicaltrials-gov-nct03279302-glepaglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03279302-glepaglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.json#clinicaltrials-gov-nct03279302-glepaglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.md#clinicaltrials-gov-nct03279302-glepaglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct03279302-glepaglutide","version":1,"domain":"Clinical trials","dateInSource":"2017-12-22","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["glepaglutide"],"peptides":[{"slug":"glepaglutide","url":"https://peptidescanner.com/peptides/glepaglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03279302","sourceIds":["ctg-observation-nct03279302-2017-12-22-dc50408f6a0e"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03279302 at 2026-11-16T01:46:56.290Z. Its registry update date was 2017-12-22, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct03279302-2017-12-22-dc50408f6a0e"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03279302 at 2026-11-16T01:46:56.290Z. Its registry update date was 2017-12-22, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct03279302-2017-12-22-dc50408f6a0e"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03279302-2017-12-22-dc50408f6a0e"]}],"sources":[{"id":"ctg-observation-nct03279302-2017-12-22-dc50408f6a0e","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03279302 · retained source version 2017-12-22:dc50408f6a0efc0c865db83cf7865bb605dfb21efc12d9e14189a8f404facd54","url":"https://clinicaltrials.gov/study/NCT03279302"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"530f9f5e5bf7aa48a4c29b0edf92370d8566b9a3bb9890f0634a80fc9a4b0073","tierARecordSha256":"0985607b2e31a6b5f9055eb3b726bbd5fee41127f0d0748e2f5bc6a34856baf2"},"integrity":{"algorithm":"sha256","contentSha256":"fc0e4b8e72e5357ecd81bbe4d40015d6937fb87fb1cc139871994867993b4388"}},"clinicaltrials-gov-nct03690206-glepaglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03690206-glepaglutide:v1","objectPathId":"clinicaltrials-gov-nct03690206-glepaglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03690206-glepaglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.json#clinicaltrials-gov-nct03690206-glepaglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.md#clinicaltrials-gov-nct03690206-glepaglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct03690206-glepaglutide","version":1,"domain":"Clinical trials","dateInSource":"2025-07-17","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["glepaglutide"],"peptides":[{"slug":"glepaglutide","url":"https://peptidescanner.com/peptides/glepaglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03690206","sourceIds":["ctg-observation-nct03690206-2025-07-17-3e2aff5817a1"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03690206 at 2026-11-16T01:46:56.290Z. Its registry update date was 2025-07-17, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct03690206-2025-07-17-3e2aff5817a1"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03690206 at 2026-11-16T01:46:56.290Z. Its registry update date was 2025-07-17, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct03690206-2025-07-17-3e2aff5817a1"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03690206-2025-07-17-3e2aff5817a1"]}],"sources":[{"id":"ctg-observation-nct03690206-2025-07-17-3e2aff5817a1","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03690206 · retained source version 2025-07-17:3e2aff5817a151ae789399cdd4bd45d445559960e7ea0c24fc977217631eb957","url":"https://clinicaltrials.gov/study/NCT03690206"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ccc8450843977d8431ab43ce724128d83ee430055951a283e59e48834728353a","tierARecordSha256":"1de18ca852db480b9ab81d44420bba5a83a77023b07775faf21d3f60a3562ff8"},"integrity":{"algorithm":"sha256","contentSha256":"cd8b3f8c67790d604190bc8f12762d82f0243d7bb08ffbf7b630e823d1b0c770"}},"clinicaltrials-gov-nct03905707-glepaglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03905707-glepaglutide:v1","objectPathId":"clinicaltrials-gov-nct03905707-glepaglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03905707-glepaglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.json#clinicaltrials-gov-nct03905707-glepaglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.md#clinicaltrials-gov-nct03905707-glepaglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct03905707-glepaglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-09-08","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["glepaglutide"],"peptides":[{"slug":"glepaglutide","url":"https://peptidescanner.com/peptides/glepaglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03905707","sourceIds":["ctg-observation-nct03905707-2026-09-08-11059977e74d"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03905707 at 2026-11-16T01:46:56.290Z. Its registry update date was 2026-09-08, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct03905707-2026-09-08-11059977e74d"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03905707 at 2026-11-16T01:46:56.290Z. Its registry update date was 2026-09-08, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct03905707-2026-09-08-11059977e74d"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03905707-2026-09-08-11059977e74d"]}],"sources":[{"id":"ctg-observation-nct03905707-2026-09-08-11059977e74d","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03905707 · retained source version 2026-09-08:11059977e74d5a72c90793b0c13b1c07753e002ccbfea3f4c86b86e077f7ccc0","url":"https://clinicaltrials.gov/study/NCT03905707"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8e09318864e4104535164c827f2ec22c4467a6920d58baa38654954105e5df08","tierARecordSha256":"620c5417e28f0d04cf43515184c45960dbaa40e8e5cbd5901cee43bcb0dc836d"},"integrity":{"algorithm":"sha256","contentSha256":"3d9a6c3f1959149b0605c4aaf66de5ead57f085a70c466f254145f25516139ef"}},"clinicaltrials-gov-nct04178447-glepaglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct04178447-glepaglutide:v1","objectPathId":"clinicaltrials-gov-nct04178447-glepaglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04178447-glepaglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.json#clinicaltrials-gov-nct04178447-glepaglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.md#clinicaltrials-gov-nct04178447-glepaglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct04178447-glepaglutide","version":1,"domain":"Clinical trials","dateInSource":"2020-11-18","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["glepaglutide"],"peptides":[{"slug":"glepaglutide","url":"https://peptidescanner.com/peptides/glepaglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT04178447","sourceIds":["ctg-observation-nct04178447-2020-11-18-9b37bf708af5"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT04178447 at 2026-11-16T01:46:56.290Z. Its registry update date was 2020-11-18, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct04178447-2020-11-18-9b37bf708af5"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT04178447 at 2026-11-16T01:46:56.290Z. Its registry update date was 2020-11-18, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct04178447-2020-11-18-9b37bf708af5"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct04178447-2020-11-18-9b37bf708af5"]}],"sources":[{"id":"ctg-observation-nct04178447-2020-11-18-9b37bf708af5","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT04178447 · retained source version 2020-11-18:9b37bf708af58cd3f0f5102128716c076926d303136fdb12411ff0dffb25ea2d","url":"https://clinicaltrials.gov/study/NCT04178447"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5801b4c5dc272d85a0966ad8105aba150b68090e210dee0fabc4770a27f195c6","tierARecordSha256":"b9cd85b24e58a4f7a4ac5d4a437dd62dac38d18a8a4035e823c65c19fc178a1d"},"integrity":{"algorithm":"sha256","contentSha256":"fa1cd0384bc2f258e1800f02dc9a129f5f670b5ddf4e426e2b997a350c9d19fa"}},"clinicaltrials-gov-nct04318743-glepaglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct04318743-glepaglutide:v1","objectPathId":"clinicaltrials-gov-nct04318743-glepaglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04318743-glepaglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.json#clinicaltrials-gov-nct04318743-glepaglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.md#clinicaltrials-gov-nct04318743-glepaglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct04318743-glepaglutide","version":1,"domain":"Clinical trials","dateInSource":"2021-07-14","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["glepaglutide"],"peptides":[{"slug":"glepaglutide","url":"https://peptidescanner.com/peptides/glepaglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT04318743","sourceIds":["ctg-observation-nct04318743-2021-07-14-c3c401151845"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT04318743 at 2026-11-16T01:46:56.290Z. Its registry update date was 2021-07-14, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct04318743-2021-07-14-c3c401151845"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT04318743 at 2026-11-16T01:46:56.290Z. Its registry update date was 2021-07-14, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct04318743-2021-07-14-c3c401151845"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct04318743-2021-07-14-c3c401151845"]}],"sources":[{"id":"ctg-observation-nct04318743-2021-07-14-c3c401151845","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT04318743 · retained source version 2021-07-14:c3c40115184512d49b736177a5b21cfecdae03efd4ffc9b77d01b40f6bcb8b52","url":"https://clinicaltrials.gov/study/NCT04318743"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0fb8c4c1d563df109fa7a6b2082baf178c1ec305ad825fd393c97221d1f6b221","tierARecordSha256":"c49cf92f4ce39a46830a26a53e66d5b0b6d3b7e7f681c2a5e6f8c877aae9eaae"},"integrity":{"algorithm":"sha256","contentSha256":"4a3575db569620ba03c96928d56f8389e625b7bba1d81bd92afea496900c3de6"}},"clinicaltrials-gov-nct04881825-glepaglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct04881825-glepaglutide:v1","objectPathId":"clinicaltrials-gov-nct04881825-glepaglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04881825-glepaglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.json#clinicaltrials-gov-nct04881825-glepaglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.md#clinicaltrials-gov-nct04881825-glepaglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct04881825-glepaglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-09-08","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["glepaglutide"],"peptides":[{"slug":"glepaglutide","url":"https://peptidescanner.com/peptides/glepaglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT04881825","sourceIds":["ctg-observation-nct04881825-2026-09-08-eaf163f36be9"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT04881825 at 2026-11-16T01:46:56.290Z. Its registry update date was 2026-09-08, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct04881825-2026-09-08-eaf163f36be9"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT04881825 at 2026-11-16T01:46:56.290Z. Its registry update date was 2026-09-08, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct04881825-2026-09-08-eaf163f36be9"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct04881825-2026-09-08-eaf163f36be9"]}],"sources":[{"id":"ctg-observation-nct04881825-2026-09-08-eaf163f36be9","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT04881825 · retained source version 2026-09-08:eaf163f36be9700764a5ef47014a2bce6716739462518d1ce3cadf802d2d7c04","url":"https://clinicaltrials.gov/study/NCT04881825"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1ce3eebf3428809368e62c0b3778afe7d1589d5f42616993da66e52ca6e1bd31","tierARecordSha256":"2c67d318a965b9e2faa153dbf576e5547fe600cc99295f84f05327887adea558"},"integrity":{"algorithm":"sha256","contentSha256":"432ea23e90e7ff2637d05fbbcf20c75534bf78ed63bba4a8ebf6aaaa1e05bb11"}},"clinicaltrials-gov-nct04991311-glepaglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct04991311-glepaglutide:v1","objectPathId":"clinicaltrials-gov-nct04991311-glepaglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04991311-glepaglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.json#clinicaltrials-gov-nct04991311-glepaglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.md#clinicaltrials-gov-nct04991311-glepaglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct04991311-glepaglutide","version":1,"domain":"Clinical trials","dateInSource":"2024-11-22","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["glepaglutide"],"peptides":[{"slug":"glepaglutide","url":"https://peptidescanner.com/peptides/glepaglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT04991311","sourceIds":["ctg-observation-nct04991311-2024-11-22-7052534a6c8e"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT04991311 at 2026-11-16T01:46:56.290Z. Its registry update date was 2024-11-22, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct04991311-2024-11-22-7052534a6c8e"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT04991311 at 2026-11-16T01:46:56.290Z. Its registry update date was 2024-11-22, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct04991311-2024-11-22-7052534a6c8e"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct04991311-2024-11-22-7052534a6c8e"]}],"sources":[{"id":"ctg-observation-nct04991311-2024-11-22-7052534a6c8e","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT04991311 · retained source version 2024-11-22:7052534a6c8ee0696d8734e5e5f23a1d20f87287c6e8b1b3cac450a9fdd07ebe","url":"https://clinicaltrials.gov/study/NCT04991311"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a9f33bd4fdbb072af512e1ac2fa81118954e364be4a71a961261a96e3ef7b3fd","tierARecordSha256":"1532ec9d6b986e6b2bbcc7ca9cdc2ae9e5f211efa03124e183fcdb3d85db2f19"},"integrity":{"algorithm":"sha256","contentSha256":"ea347f08befd2190f6cf0f65a27aee058ab1521455966e201b07cfe9358ff85b"}},"clinicaltrials-gov-nct07197944-glepaglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07197944-glepaglutide:v1","objectPathId":"clinicaltrials-gov-nct07197944-glepaglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07197944-glepaglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.json#clinicaltrials-gov-nct07197944-glepaglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.md#clinicaltrials-gov-nct07197944-glepaglutide-v1"},"story":{"slug":"clinicaltrials-gov-nct07197944-glepaglutide","version":1,"domain":"Clinical trials","dateInSource":"2026-09-29","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["glepaglutide"],"peptides":[{"slug":"glepaglutide","url":"https://peptidescanner.com/peptides/glepaglutide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07197944","sourceIds":["ctg-observation-nct07197944-2026-09-29-d17b66ad0d02"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07197944 at 2026-11-16T01:46:56.290Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct07197944-2026-09-29-d17b66ad0d02"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07197944 at 2026-11-16T01:46:56.290Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was glepaglutide.","sourceIds":["ctg-observation-nct07197944-2026-09-29-d17b66ad0d02"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07197944-2026-09-29-d17b66ad0d02"]}],"sources":[{"id":"ctg-observation-nct07197944-2026-09-29-d17b66ad0d02","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07197944 · retained source version 2026-09-29:d17b66ad0d028f8ed1ae307ba724f47af9774ddda187807aa0977fb1675d8eb3","url":"https://clinicaltrials.gov/study/NCT07197944"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"60f8542a043b9aa16a7fed798d20d3c61dae099f6d45da0fce577b63cb8a87cc","tierARecordSha256":"ea6b384d8cf0088462d8f018fd0a53643433a357cb111e3646d970535d8e4f79"},"integrity":{"algorithm":"sha256","contentSha256":"b6be0cbb0467626803fa8ef1fe76aa4a9f6e32736b824956a314eb0b9e750229"}},"pubmed-pmid-41816796-glepaglutide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41816796-glepaglutide:v1","objectPathId":"pubmed-pmid-41816796-glepaglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41816796-glepaglutide/","json":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.json#pubmed-pmid-41816796-glepaglutide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/glepaglutide.md#pubmed-pmid-41816796-glepaglutide-v1"},"story":{"slug":"pubmed-pmid-41816796-glepaglutide","version":1,"domain":"Literature metadata","dateInSource":"2026-09-02","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["glepaglutide"],"peptides":[{"slug":"glepaglutide","url":"https://peptidescanner.com/peptides/glepaglutide/"}]},"claims":[{"id":"headline","text":"Exploring the disease burden and quality of life in patients with short bowel syndrome with intestinal failure: Insights from exit interviews in the glepaglutide EASE SBS-1 phase 3 trial.","sourceIds":["pubmed-observation-pmid-41816796-2026-09-02-edf436b5b2a7"]},{"id":"summary","text":"PubMed lists PMID 41816796 in Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, Multicenter Study, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug glepaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41816796-2026-09-02-edf436b5b2a7"]},{"id":"paragraph-1","text":"PubMed lists PMID 41816796 in Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, Multicenter Study, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug glepaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41816796-2026-09-02-edf436b5b2a7"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41816796-2026-09-02-edf436b5b2a7"]}],"sources":[{"id":"pubmed-observation-pmid-41816796-2026-09-02-edf436b5b2a7","name":"PubMed","sourceClass":"A","title":"Exploring the disease burden and quality of life in patients with short bowel syndrome with intestinal failure: Insights from exit interviews in the glepaglutide EASE SBS-1 phase 3 trial. · retained source version 1:2026-09-02:current:edf436b5b2a7a95e758e93ebedd17071036bdc1df73c58e72f50fb0fc2c837c1","url":"https://pubmed.ncbi.nlm.nih.gov/41816796/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"71e7020bfc4ca4247f56b7a13dc5a0215a898144f6027e8104669ab48a6bd178","tierARecordSha256":"ded2ae040b8f9f9167074da6c47f57d48056496f9b9811b11e26cdc23e5c012f"},"integrity":{"algorithm":"sha256","contentSha256":"00e3475615ec40172f4b2cb660cea9a339a5d79a3a65cc6e813d6332af20528b"}}}}
